prapexin 0.18 milligram tablets
rowex ltd - pramipexole - tablets - 0.18 milligram - dopamine agonists
prapexin 0.7 milligram tablets
rowex ltd - pramipexole - tablets - 0.7 milligram - dopamine agonists
sildenafil teva 50 milligram tablets chewable
teva pharma b.v. - sildenafil citrate - tablets chewable - 50 milligram
sildenafil teva 100 milligram tablets chewable
teva pharma b.v. - sildenafil citrate - tablets chewable - 100 milligram
actaze tablets 45 mg pioglitazone (as hydrochloride) 45 mg tablet blister pack
arrow pharma pty ltd - pioglitazone hydrochloride, quantity: 49.6 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; carmellose calcium; magnesium stearate; hyprolose - treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise: as monotherapy;. as dual therapy to improve glycaemic control, in combination with metformin or sulfonylurea in combination with insulin; as triple therapy to improve glycaemic control, in combination with metformin and sulfonylurea.
actaze tablets 30 mg pioglitazone (as hydrochloride) 30 mg tablet blister pack
arrow pharma pty ltd - pioglitazone hydrochloride, quantity: 33.07 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; hyprolose; magnesium stearate; carmellose calcium - treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise: as monotherapy;. as dual therapy to improve glycaemic control, in combination with metformin or sulfonylurea in combination with insulin; as triple therapy to improve glycaemic control, in combination with metformin and sulfonylurea.
actaze tablets 15 mg pioglitazone (as hydrochloride) 15 mg tablet blister pack
arrow pharma pty ltd - pioglitazone hydrochloride, quantity: 16.53 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; carmellose calcium; magnesium stearate; hyprolose - treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise: as monotherapy;. as dual therapy to improve glycaemic control, in combination with metformin or sulfonylurea in combination with insulin; as triple therapy to improve glycaemic control, in combination with metformin and sulfonylurea.
hequinel tablets 200 mg hydroxychloroquine sulfate 200 mg tablet bottle
arrotex pharmaceuticals pty ltd - hydroxychloroquine sulfate, quantity: 200 mg - tablet - excipient ingredients: colloidal anhydrous silica; calcium hydrogen phosphate; hypromellose; polysorbate 80; pregelatinised maize starch; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - rheumatoid arthritis; mild systemic and discoid lupus erythematosus; the suppression and treatment of malaria.
hydroxychloroquine gh tablets hydroxychloroquine sulfate 200 mg tablets bottle
generic health pty ltd - hydroxychloroquine sulfate, quantity: 200 mg - tablet - excipient ingredients: hypromellose; magnesium stearate; calcium hydrogen phosphate; polysorbate 80; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - rheumatoid arthritis; mild systemic and discoid lupus erythematosus; the suppression and treatment of malaria.
arw olmesartan hctz 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film coated tablets blister pack
arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 20 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: hypromellose; purified water; hyprolose; lactose monohydrate; magnesium stearate; microcrystalline cellulose; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.